GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemCell Institute (TSE:7096) » Definitions » ROC (Joel Greenblatt) %

StemCell Institute (TSE:7096) ROC (Joel Greenblatt) % : 0.00% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is StemCell Institute ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. StemCell Institute's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 0.00%.

The historical rank and industry rank for StemCell Institute's ROC (Joel Greenblatt) % or its related term are showing as below:

TSE:7096' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 25.44   Med: 63.02   Max: 408.3
Current: 61.42

During the past 7 years, StemCell Institute's highest ROC (Joel Greenblatt) % was 408.30%. The lowest was 25.44%. And the median was 63.02%.

TSE:7096's ROC (Joel Greenblatt) % is ranked better than
94.28% of 1398 companies
in the Biotechnology industry
Industry Median: -317.92 vs TSE:7096: 61.42

StemCell Institute's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -32.00% per year.


StemCell Institute ROC (Joel Greenblatt) % Historical Data

The historical data trend for StemCell Institute's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemCell Institute ROC (Joel Greenblatt) % Chart

StemCell Institute Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial 408.30 25.44 34.73 45.93 63.02

StemCell Institute Quarterly Data
Mar18 Mar19 Dec19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.13 73.61 82.09 34.14 -

Competitive Comparison of StemCell Institute's ROC (Joel Greenblatt) %

For the Biotechnology subindustry, StemCell Institute's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


StemCell Institute's ROC (Joel Greenblatt) % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemCell Institute's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where StemCell Institute's ROC (Joel Greenblatt) % falls into.


;
;

StemCell Institute ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1588.31 + 42.262 + 38.928) - (215.273 + 0 + 3542.641)
=-2088.414

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1742.855 + 42.491 + 60.575000000001) - (175.62 + 0 + 3790.589)
=-2120.288

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of StemCell Institute for the quarter that ended in Sep. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0/( ( (665.155 + max(-2088.414, 0)) + (656.042 + max(-2120.288, 0)) )/ 2 )
=0/( ( 665.155 + 656.042 )/ 2 )
=0/660.5985
=0.00 %

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


StemCell Institute  (TSE:7096) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


StemCell Institute ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of StemCell Institute's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


StemCell Institute Business Description

Traded in Other Exchanges
N/A
Address
Shimbashi, Minato-ku, Tamuracho Building, Matsuoka, Tokyo, JPN, 105-0004
StemCell Institute is engaged in Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's own cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood.

StemCell Institute Headlines

No Headlines